Anumana’s AI-enabled algorithm for the early detection of pulmonary hypertension (PH) has been cleared for use by the FDA.
FAYETTEVILLE, GA, UNITED STATES, April 2, 2026 /EINPresswire.com/ -- A new artificial intelligence method enables ...
PH is a progressive, life-threatening pulmonary vascular disease estimated to affect up to 1% of the global population. 1 It is often difficult to diagnose 2 due to non-specific early symptoms, such ...
Published in the journal Fire, the study titled “Artificial Intelligence for Geospatial Decision Support in Rural Wildfire Management: A Configurational Mapping Review” provides a systematic analysis ...
WEST LAFAYETTE, Ind. — Patent-pending imaging technologies created in Purdue University’s College of Engineering could be developed and commercialized for applications as diverse as medical imaging, ...
Proteogenomics explores how genetic information translates into protein expression and function, and the role of changes across DNA, RNA, and proteins in influencing disease development and ...
Anumana, a leader in AI-powered cardiovascular detection algorithms, today announced it has been named to Fast Company's ...
Medical Device Network on MSN
FDA approves Anumana’s pulmonary hypertension algorithm
The algorithm integrates with EHR systems and ECG platforms, operating within the health system without external data ...
Existing loss of well control event indicators fall short of predicting events in an accurate and timely manner due to a lack ...
OMRON Electronic Components has launched the B5T-007003 Human Vision Component (B5T HVC-P2), a module specialised for human ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果